There is no real treatment for<unk> , rather the best method in management of the disease is to control the underlying rheumatoid arthritis. Immunosuppressive therapy for RA often improves granulocytopenia and splenomegaly; this finding reflects the fact that<unk>  is an immune-mediated disease. A major challenge in treating<unk>  is recurring infection caused by neutropenia. Therefore, in order to decide upon and begin treatment, the cause and relationship of neutropenia with the overall condition must be well understood. Most of the traditional medications used to treat RA have been used in the treatment of<unk> . No well-conducted, randomized, controlled trials support the use of any single agent. Most reports on treatment regimens involve small numbers of patients. Splenectomy may improve neutropenia in severe disease. Use of rituximab and leflunomide have been proposed. Use of gold therapy has also been described.
Felty's syndrome
SUNCT syndrome
Crome syndrome
Eosinophilia–myalgia syndrome
Michels Caskey syndrome
Roemheld syndrome
Mendelson's syndrome
MASA syndrome